OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis
Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni, et al.
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 3, pp. 440-447
Closed Access | Times Cited: 8
Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni, et al.
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 3, pp. 440-447
Closed Access | Times Cited: 8
Showing 8 citing articles:
Characterization for the Similarity Assessment Between the Proposed Biosimilar SB17 and Ustekinumab Reference Product Using State-of-the-Art Analytical Methods
Sung-Yong Yang, Changsoo Lee, Kwang Il Hwang, et al.
Drugs in R&D (2025)
Open Access
Sung-Yong Yang, Changsoo Lee, Kwang Il Hwang, et al.
Drugs in R&D (2025)
Open Access
Biosimilars for the treatment of psoriasis: a narrative review
Duc Binh Phan, Z.Z.N. Yiu
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
Duc Binh Phan, Z.Z.N. Yiu
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
Biobetters and biosimilars in Inflammatory Bowel Disease
Jacopo Fanizza, Ilaria Faggiani, Mariangela Allocca, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101992-101992
Closed Access
Jacopo Fanizza, Ilaria Faggiani, Mariangela Allocca, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101992-101992
Closed Access
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease
Konika Sharma, Brad W. deSilva, Stephen B. Hanauer
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Konika Sharma, Brad W. deSilva, Stephen B. Hanauer
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Efficacy and safety of SYSA1902 versus reference ustekinumab in moderate-to-severe plaque psoriasis: A multicenter, randomized, phase III study
Lixin Xia, Guoying Miao, Xiumin Yang, et al.
Journal of the American Academy of Dermatology (2025)
Open Access
Lixin Xia, Guoying Miao, Xiumin Yang, et al.
Journal of the American Academy of Dermatology (2025)
Open Access
Ustekinumab Biosimilars
Elena Carmona‐Rocha, L. Puig
Biologics (2024) Vol. 4, Iss. 4, pp. 407-424
Open Access | Times Cited: 1
Elena Carmona‐Rocha, L. Puig
Biologics (2024) Vol. 4, Iss. 4, pp. 407-424
Open Access | Times Cited: 1
Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52
Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Quoi de neuf en thérapeutique dermatologique ?
C. Paul
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S45-8S54
Closed Access
C. Paul
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S45-8S54
Closed Access
